Investigation of Apoptosis-mediated Cytotoxic Effects of Royal Jelly on HL-60 Cells
Öz
In recent years, the use of nontoxic natural products that can be effective on cancer cells as new agents has attracted the attention of scientists in order to reduce the negative side effects of existing cancer drugs and their toxicity to normal cells. Some in vivo and in vitro studies have shown that royal jelly (RJ) inhibits cell proliferation and induces apoptosis. In this research, we aimed to investigate the effects of RJ on proliferative and apoptotic processes in the human acute promyelocytic leukemia cell line (HL-60). The HL60 cell line was treated with different concentrations of RJ for 24, 48, and 72 hours. The half maximum inhibitory concentration (IC50) of RJ was determined using 3-(4.5 dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide test (MTT) and the proliferation activity of HL-60 cells was evaluated. Flow cytometry analysis was performed to measure apoptosis in HL-60 cells. IC50 values for RJ were calculated as 13.98, 6.45, and 2.06 mg/mL for 24, 48, and 72 hours, respectively. Flow cytometry results also showed that RJ had apoptotic effects at the concentrations found. The results showed that RJ treatment significantly induced apoptosis and reduced the proliferation of HL-60 cells. This study shows that RJ can be a complementary treatment against HL-60 acute myeloid leukemia cells due to its anticancer and antiproliferative effects.
Anahtar Kelimeler
Destekleyen Kurum
Çalışma için herhangi bir kurumdan destek alınmamıştır.
Etik Beyan
Araştırma ve yayın etiği açısından herhangi bir sorun bulunmamaktadır.
Teşekkür
Laboratuvar olanakları ve gerekli malzemeler konusunda vermiş olduğu desteklerden dolayı için Gaziantep Üniversitesi Tıbbi Biyokimya öğretim görevlisi Prof. Dr. Seyithan TAYSI'ya teşekkür ederiz.
Kaynakça
- Albalawi, A. E., Althobaiti, N. A., Alrdahe, S. S., Alhasani, R. H., Alaryani, F. S. & BinMowyna, M. N. (2021). Anti-Tumor Effects of Queen Bee Acid (10-Hydroxy-2-Decenoic Acid) Alone and in Combination with Cyclophosphamide and Its Cellular Mechanisms against Ehrlich Solid Tumor in Mice. Molecules 26(22), 7021. DOI: 10.3390/molecules26227021
- Albalawi, A. E., Althobaiti, N. A., Alrdahe, S. S., Alhasani, R. H., Alaryani, F. S. & BinMowyna, M. N. (2022). Antitumor Activity of Royal Jelly and Its Cellular Mechanisms against Ehrlich Solid Tumor in Mice. BioMed Research International 2022, 7233997. DOI: 10.1155/2022/7233997
- Ayna, A. & Darendelioglu, E. (2022). Evaluation of the Biological Activities of Royal Jelly on Prostate and Breast Cancer Cells. Türk Doğa ve Fen Dergisi 11. DOI: 10.46810/tdfd.1149604
- Ayna, A., Tunç, A., ÖZbolat, S., Bengü, A., Aykutoğlu, G., Canli, D., Polat, R., Ciftci, M. & Darendelioglu, E. (2021). Anticancer, and antioxidant activities of royal jelly on HT-29 colon cancer cells and melissopalynological analysis. Turkish Journal of Botany, 45, 809-819. DOI: 10.3906/bot-2109-8
- Bagameri, L., Botezan, S., Bobis, O., Bonta, V. & Dezmirean, D. S. (2023). Molecular Insights into Royal Jelly Anti-Inflammatory Properties and Related Diseases. Life (Basel), 13(7), 1573. DOI: 10.3390/life13071573
- Berthenet, K., Castillo Ferrer, C., Fanfone, D., Popgeorgiev, N., Neves, D., Bertolino, P., Gibert, B., Hernandez-Vargas, H. & Ichim, G. (2020). Failed Apoptosis Enhances Melanoma Cancer Cell Aggressiveness. Cell Reports 31(10), 107731. DOI: 10.1016/j.celrep.2020.107731
- Caliskan, E., Ayna, A., Tunç, A., ÖZbolat, S., Bengü, A., Aykutoğlu, G., Ciftci, M. & Darendelioglu, E. (2021). Antioxidant Activities of Bingöl Royal Jelly on SH-SY5Y Cells. International Journal of Nature and Life Sciences 5. DOI: 10.47947/ijnls.1008223
- Gismondi, A., Trionfera, E., Canuti, L., Di Marco, G. & Canini, A. (2017). Royal jelly lipophilic fraction induces antiproliferative effects on SH-SY5Y human neuroblastoma cells. Oncology Reports 38(3), 1833-1844. DOI: 10.3892/or.2017.5851
- Gullett, N. P., Ruhul Amin, A. R., Bayraktar, S., Pezzuto, J. M., Shin, D. M., Khuri, F. R., Aggarwal, B. B., Surh, Y. J. & Kucuk, O. (2010). Cancer prevention with natural compounds. Seminars Oncology 37(3), 258-281. DOI: 10.1053/j.seminoncol.2010.06.014
- Hegde, M., Girisa, S., Naliyadhara, N., Kumar, A., Alqahtani, M. S., Abbas, M., Mohan, C. D., Warrier, S., Hui, K. M., Rangappa, K. S., Sethi, G. & Kunnumakkara, A. B. (2023). Natural compounds targeting nuclear receptors for effective cancer therapy. Cancer and Metastasis Reviews 42(3), 765-822. DOI: 10.1007/s10555- 022-10068-w